Navigating International Markets: A Comparison of Vanguard ETFs
Money

Navigating International Markets: A Comparison of Vanguard ETFs

authorBy Bola Sokunbi
DateJun 21, 2026
Read Time4 min
In an increasingly interconnected world, the global economy plays a pivotal role. The advancements in technology and communication have simplified international travel and trade, making it essential for investment portfolios to mirror this global trend. While the American stock market remains the largest worldwide, with many leading corporations headquartered in the U.S., numerous exceptional international equities warrant consideration for investment. For most individual investors, Exchange-Traded Funds (ETFs) represent the most effective way to gain international exposure, bypassing linguistic and regulatory hurdles often associated with foreign market investments. This discussion will compare two prominent international ETFs from Vanguard: the Vanguard Total International Stock ETF (VXUS) and the Vanguard FTSE All-World ex-US Small-Cap ETF (VSS), both from a reputable leader in the ETF sector.

Unlock Global Growth: A Deep Dive into Vanguard's International ETF Offerings

Grasping the Global Investment Landscape: Developed vs. Emerging Markets

To effectively engage in global investing, it is crucial to differentiate between developed and emerging markets. Investors accustomed to the U.S. stock market might overlook the inherent stability of the American economy, its governmental structure, and its stock exchange system. This stability is not uniformly present across all nations. Developed markets encompass established economies like the U.S., Japan, Sweden, and France. Conversely, emerging markets, such as India, Brazil, and South Africa, offer significant growth prospects but are often accompanied by higher risks due to less stable national conditions. A well-rounded investment strategy typically includes exposure to both types of markets, making it vital to understand each ETF's specific focus.

Vanguard's International ETFs: Similarities and Distinctions

Both Vanguard ETFs, VXUS and VSS, share several appealing characteristics. As products of Vanguard, a trusted name in the investment community, they offer accessibility with a minimum investment of just $1, making them suitable for any investor's budget. Furthermore, both funds boast remarkably low expense ratios: VXUS charges 0.05% and VSS charges a mere 0.06%. This translates to an annual cost of only $5 and $6, respectively, on a $10,000 investment, providing a cost-effective solution for investors seeking international diversification without the burden of individual stock analysis. Both ETFs also exhibit comparable exposure to emerging markets, with VXUS allocating 26.3% and VSS slightly more aggressively at 28.7%.

Strategic Variations in ETF Composition and Performance

The primary distinction between these two ETFs lies in their investment approaches and structural designs. The Vanguard Total International Stock ETF (VXUS) diversifies across thousands of international companies, featuring a median market capitalization of $54.8 billion. In contrast, the Vanguard FTSE All-World ex-US Small-Cap ETF (VSS), as its name implies, concentrates on small-cap equities, with a median market cap of just $2.5 billion. Small-cap stocks are generally known for their higher volatility but also their potential for superior long-term growth. This difference is reflected in their historical performance: VSS has delivered an annualized total return of 9.79% since 2009, outperforming VXUS's 6.73% since 2011.

Choosing the Right International ETF for Your Portfolio

The selection between VXUS and VSS hinges on an investor's risk tolerance and financial objectives. While the FTSE All-World ex-US Small-Cap ETF (VSS) has demonstrated impressive returns, its focus on small-cap non-U.S. stocks can lead to significant market fluctuations. For investors comfortable with such volatility, VSS might be the ideal choice. However, for those who prefer a more stable investment, perhaps due to age, risk aversion, or other personal considerations, the Vanguard Total International Stock ETF (VXUS) would likely be a more suitable option. Given that both ETFs originate from Vanguard and feature similar fees and minimum investment requirements, the ultimate decision rests on individual comfort levels with market risk.

Making Informed Investment Decisions

Before committing to an investment in the Vanguard Total International Stock ETF, it is prudent to consider various factors. Expert analysis suggests that while VXUS is a solid choice for international exposure, other opportunities may offer even greater growth potential. For instance, some investment advisories identify top stock picks designed for long-term appreciation that could yield substantial returns. Reviewing such recommendations and considering a broader range of investment vehicles is advisable to maximize portfolio growth.

More Articles
Money
SpaceX vs. Nvidia: A Trillion-Dollar Revenue Showdown
Both SpaceX and Nvidia, leaders in AI and innovation, have ambitious forecasts of reaching $1 trillion in revenue. This analysis delves into their current market positions, growth trajectories, and the viability of their respective trillion-dollar goals, ultimately assessing which company presents a more compelling investment opportunity. While SpaceX shows promising developments in space and connectivity, Nvidia's established leadership in AI chips and clear revenue path make it a more attractive buy.
By Ramit SethiJun 21, 2026
Money
Maximizing Dividend Income: A Deep Dive into Pfizer and Johnson & Johnson Investments
Investing in 500 shares each of Pfizer and Johnson & Johnson can generate a substantial annual passive income of $3,540 from a total investment of approximately $127,000, achieving a combined yield of 2.79%. Johnson & Johnson offers a stable dividend backed by a robust balance sheet and consistent increases, while Pfizer provides a higher yield influenced by recent stock performance and strategic focus on its core product pipeline. This analysis highlights how these pharmaceutical giants can contribute significantly to a diversified dividend portfolio.
By Vicki RobinJun 21, 2026
Money
Kevin O'Leary's Millionaire Blueprint: Turning a $65K Salary into Millions Through Strategic Saving and Investing
Kevin O'Leary, the renowned 'Shark Tank' investor, reveals a simple yet powerful strategy for anyone earning $65,000 annually to potentially amass millions. His core philosophy, 'Save. Invest. Compound. It's that simple,' emphasizes consistently setting aside 15% of all income and leveraging the power of long-term market growth and compound interest. This approach, supported by investment giants like Warren Buffett, encourages disciplined saving, smart spending habits, and active debt management to build substantial wealth over time.
By Ramit SethiJun 21, 2026
Money
Tesla's Robotaxi Strategy: Low Prices Amidst Fierce Competition in Texas
Tesla's robotaxi fleet in Texas is significantly smaller than its competitors, with only 69 vehicles compared to Waymo's 620. Despite this, Tesla is strategically undercutting its rivals by offering rides at prices over 20% lower. This aggressive pricing aims to gather more data and expand its market presence, even if it means longer wait times for customers. Bank of America maintains a 'Buy' rating on Tesla, foreseeing future monetization of its autonomous driving technology.
By Mr. Money MustacheJun 21, 2026
Money
S&P 500's CAPE Ratio Signals Potential Market Downturn
The S&P 500's Cyclically Adjusted Price-to-Earnings (CAPE) ratio is currently at an elevated level of 41, suggesting an overvalued market reminiscent of historical bubbles. This metric, developed by Robert Shiller, indicates that investors are paying high prices for long-term earnings, a situation that has historically led to disappointing returns. Investors should exercise caution and consider diversified portfolios with a cash reserve.
By T. Harv EkerJun 21, 2026